Dec 15 (Reuters) - Candel Therapeutics Inc CADL.O :
* CANDEL THERAPEUTICS INC - JASON A. AMELLO TO RESIGN FROM
HIS
POSITION AS COMPANY’S CHIEF FINANCIAL OFFICER EFFECTIVE JANUARY
12, 2024
* CANDEL THERAPEUTICS INC - AMELLO WILL REMAIN AN ADVISOR TO
THE
COMPANY IN ORDER TO SUPPORT THE TRANSITION OF HIS
RESPONSIBILITIES
* CANDEL THERAPEUTICS INC: EFFECTIVE UPON MR. AMELLO'S
CESSATION
OF SERVICE AS CFO CO INTENDS TO APPOINT CHARLES SCHOCH AS CO'S
INTERIM CFO
Source text for Eikon: [ID: https://www.sec.gov/ix?doc=/Archives/edgar/data/1841387/000095017023070509/cadl-20231211.htm
]
Further company coverage: CADL.O
((Reuters.Briefs@thomsonreuters.com;))